Literature DB >> 20370656

Adenosine receptor modeling: what does the A2A crystal structure tell us?

Diego Dal Ben1, Catia Lambertucci, Gabriella Marucci, Rosaria Volpini, Gloria Cristalli.   

Abstract

For a long time, there have been no experimentally determined structural data for any adenosine receptor (AR) and the only approach available for making structure/function correlations about these proteins has been homology modeling. While the early attempts to model these receptors followed the crystallization of bacteriorhodopsin, the cryo-microscopy studies of bovine and frog rhodopsin, and the modeling of a Calpha-template for the TM helices in the rhodopsin family of GPCRs, the crystallization of bovine rhodopsin by Palczewski was of extreme importance as it first provided the crystal structure of an eukaryotic GPCR to be used as template for more realistic homology models. Since then, rhodopsin-based modeling became the routine approach to develop AR structural models that proved to be useful for interpretation of site-directed mutagenesis data and for molecular docking studies. The recently reported crystal structures of the adrenergic beta1 and beta2 receptors only partially confirmed the structural features showed by bovine rhodopsin, raising a question about which template would have been better for further modeling of ARs. Such question remained actually not-answered, due to the publication in late 2008 of the crystal structure of human adenosine A(2A) receptor (AA(2A)R). Since its publication, this structure has been used for ligands docking analysis and has provided a high similarity template for homology modeling of the other AR subtypes. Still, the AA(2A)R crystal structure allows to verify the hypotheses that were made on the basis of the previously reported homology modeling and molecular docking.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20370656     DOI: 10.2174/156802610791293145

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  12 in total

Review 1.  G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.

Authors:  Kenneth A Jacobson; Ramachandran Balasubramanian; Francesca Deflorian; Zhan-Guo Gao
Journal:  Purinergic Signal       Date:  2012-02-29       Impact factor: 3.765

2.  Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine.

Authors:  Andrew S Doré; Nathan Robertson; James C Errey; Irene Ng; Kaspar Hollenstein; Ben Tehan; Edward Hurrell; Kirstie Bennett; Miles Congreve; Francesca Magnani; Christopher G Tate; Malcolm Weir; Fiona H Marshall
Journal:  Structure       Date:  2011-09-07       Impact factor: 5.006

3.  Discovery of 1,2,4-triazine derivatives as adenosine A(2A) antagonists using structure based drug design.

Authors:  Miles Congreve; Stephen P Andrews; Andrew S Doré; Kaspar Hollenstein; Edward Hurrell; Christopher J Langmead; Jonathan S Mason; Irene W Ng; Benjamin Tehan; Andrei Zhukov; Malcolm Weir; Fiona H Marshall
Journal:  J Med Chem       Date:  2012-01-27       Impact factor: 7.446

Review 4.  Progress in structure based drug design for G protein-coupled receptors.

Authors:  Miles Congreve; Christopher J Langmead; Jonathan S Mason; Fiona H Marshall
Journal:  J Med Chem       Date:  2011-06-15       Impact factor: 7.446

5.  Identification of novel adenosine A(2A) receptor antagonists by virtual screening.

Authors:  Christopher J Langmead; Stephen P Andrews; Miles Congreve; James C Errey; Edward Hurrell; Fiona H Marshall; Jonathan S Mason; Christine M Richardson; Nathan Robertson; Andrei Zhukov; Malcolm Weir
Journal:  J Med Chem       Date:  2012-02-23       Impact factor: 7.446

6.  Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.

Authors:  Guillaume Lebon; Tony Warne; Patricia C Edwards; Kirstie Bennett; Christopher J Langmead; Andrew G W Leslie; Christopher G Tate
Journal:  Nature       Date:  2011-05-18       Impact factor: 49.962

7.  Biophysical mapping of the adenosine A2A receptor.

Authors:  Andrei Zhukov; Stephen P Andrews; James C Errey; Nathan Robertson; Benjamin Tehan; Jonathan S Mason; Fiona H Marshall; Malcolm Weir; Miles Congreve
Journal:  J Med Chem       Date:  2011-06-10       Impact factor: 7.446

8.  Synthesis, biological activity and molecular modelling studies of tricyclic alkylimidazo-, pyrimido- and diazepinopurinediones.

Authors:  Anna Drabczyńska; Tadeusz Karcz; Ewa Szymańska; Meryem Köse; Christa E Müller; Minka Paskaleva; Janina Karolak-Wojciechowska; Jadwiga Handzlik; Olga Yuzlenko; Katarzyna Kieć-Kononowicz
Journal:  Purinergic Signal       Date:  2013-04-02       Impact factor: 3.765

9.  Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists.

Authors:  Akshata Nayak; Girish Chandra; Inah Hwang; Kyunglim Kim; Xiyan Hou; Hea Ok Kim; Pramod K Sahu; Kuldeep K Roy; Jakyung Yoo; Yoonji Lee; Minghua Cui; Sun Choi; Steven M Moss; Khai Phan; Zhan-Guo Gao; Hunjoo Ha; Kenneth A Jacobson; Lak Shin Jeong
Journal:  J Med Chem       Date:  2014-02-05       Impact factor: 7.446

10.  Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor.

Authors:  Diego Dal Ben; Michela Buccioni; Catia Lambertucci; Ajiroghene Thomas; Rosaria Volpini
Journal:  In Silico Pharmacol       Date:  2013-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.